E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/13/2005 in the Prospect News PIPE Daily.

New Issue: Medical Ventures wraps private placement of stock for C$4.23 million

By Sheri Kasprzak

Atlanta, June 13 - Medical Ventures Corp. said it has closed a private placement for C$4,225,000.

The company sold 16.9 million shares at C$0.25 each.

Paul Geyer, the company's chairman, president and chief executive officer, bought 4.4 million shares.

The deal was sold through a syndicate of placement agents led by Orion Securities Inc. and including Raymond James Ltd.

The proceeds will be used for regulatory approvals and the commercialization of the Angiometrx Metricath Gemini Balloon Catheter and for general working capital.

Based in Richmond, B.C., Medical Ventures is a medical device technology company focused on technologies used to treat cardiovascular ailments.

Issuer:Medical Ventures Corp.
Issue:Stock
Amount:C$4,225,000
Shares:16.9 million
Price:C$0.25
Warrants:No
Placement agents:Orion Securities Inc. (lead); Raymond James Ltd.
Settlement date:June 13
Stock price:C$0.29 at close June 13

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.